SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-19-009059
Filing Date
2019-04-23
Accepted
2019-04-23 17:29:04
Documents
1
Period of Report
2019-04-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4005
  Complete submission text file 0001567619-19-009059.txt   5693
Mailing Address 4560 HORTON STREET,M/S R-422 EMERYVILLE CA 94608
Business Address
SOLAND DANIEL B (Reporting) CIK: 0001318485 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36830 | Film No.: 19762254

Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Issuer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations